Recently Approved Drugs: Pembrolizumab for cHL

ASCO Education

English - November 11, 2017 17:00 - 5 minutes - 2.38 MB - ★★★★ - 19 ratings
Medicine Health & Fitness Education asco oncology cancer health medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: ASCO Guidelines: Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

Next Episode: Self-Assessment: Metastatic Prostate Cancer

Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.